AI Patch Test Allergen Avoidance Letter Generator
Discovery Lens
A New Behaviors
Markets that didn't exist until people started doing something new
One-Liner
Converts patch test results (allergen reactions at 48h/96h) into personalized patient avoidance letters with product category warnings and cross-reactivity alerts.
Kill Reason
Dermatology allergen avoidance letters are a narrow workflow step in a tiny addressable market—fewer than 10,000 US practices perform routine patch testing. The output is a templated letter that takes five minutes to produce manually, and no dermatologist would budget for a standalone subscription product to automate a task that any AI assistant already handles for free.
What do you think?
Related ideas you can explore free:
killed: The CMS rule change effective January 1, 2024 moved the majority of Medicare Part D DIR fees to point-of-sale, directly addressing the retrospective exposure problem this product was designed to quantify. Building a DIR fee tracker after the primary regulatory driver has been neutralized means chasing a declining problem in a heavily regulated sector where pharmacy benefit managers and enterprise pharmacy software vendors are the natural owners of any remaining analytics needs.
killed: Leading physical therapy platforms (WebPT, Clinicient, Raintree) already ship AI-assisted documentation and Medicare billing templates. The specific Medicare functional status distinction this tool targets will be absorbed by these incumbents as a feature update, with no room for a standalone product to establish switching costs first.
killed: Automated veterinary follow-up communication is already offered by PetDesk, VitusVet, and practice management platforms such as AVImark and Cornerstone. The diagnosis-keyed personalization layer adds marginal differentiation that incumbents will replicate as a routine feature update, leaving no defensible position for a standalone product.